Harnessing Biomaterials to Engineer the Lymph Node Microenvironment for Immunity or Tolerance
Year: 2014
Type: review
Abstract: Nanoparticles, microparticles, and other biomaterials are advantageous in vaccination because these materials provide opportunities to modulate specific characteristics of immune responses. This idea of "tuning" immune responses has recently been used to combat infectious diseases and cancer, and to induce tolerance during organ transplants or autoimmune disease. Lymph nodes and other secondary lymphoid organs such as the spleen play crucial roles in determining if and how these responses develop following vaccination or immunotherapy. Thus, by manipulating the local microenvironments within these immunological command centers, the nature of systemic immune response can be controlled. This review provides recent examples that harness the interactions between biomaterials and lymph nodes or other secondary lymphoid organs to generate immunity or promote tolerance. These strategies draw on mechanical properties, surface chemistry, stability, and targeting to alter the interactions of cells, signals, and vaccine components in lymph nodes. While there are still many unanswered questions surrounding how best to design biomaterial-based vaccines to promote specific structures or functions in lymph nodes, features such as controlled release and targeting will help pave the way for the next generation of vaccines and immunotherapies that generate immune responses tuned for specific applications.
Source: The AAPS Journal
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: biomaterials, lymph node microenvironment, secondary lymphoid organs, nanoparticle vaccine, microparticles, immune tolerance, immunomodulation, vaccine targeting, controlled release, surface chemistry, mechanical properties, immunotherapy, organ transplantation, autoimmune disease, cancer immunotherapy
Open Access status: hybrid
Estimated APC paid: $5,090
Funders: National Science Foundation, Alliance for Cancer Gene Therapy, Damon Runyon Cancer Research Foundation, Alex's Lemonade Stand Foundation for Childhood Cancer, Pharmaceutical Research and Manufacturers of America Foundation, National Institutes of Health, National Institute of Allergy and Infectious Diseases
OpenAlex ID: W2034608653
